SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-000334
Filing Date
2024-01-03
Accepted
2024-01-03 17:27:07
Documents
18
Period of Report
2023-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51063
2 ex10-1.htm EX-10.1 201427
3 ex10-1_001.jpg GRAPHIC 7053
4 ex10-1_002.jpg GRAPHIC 10577
5 ex10-1_003.jpg GRAPHIC 9879
6 ex10-1_004.jpg GRAPHIC 10935
  Complete submission text file 0001493152-24-000334.txt   557691

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bfri-20231229.xsd EX-101.SCH 3976
8 XBRL DEFINITION FILE bfri-20231229_def.xml EX-101.DEF 27432
9 XBRL LABEL FILE bfri-20231229_lab.xml EX-101.LAB 37912
10 XBRL PRESENTATION FILE bfri-20231229_pre.xml EX-101.PRE 26049
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6275
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24508287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)